Bạn đang xem bản rút gọn của tài liệu. Xem và tải ngay bản đầy đủ của tài liệu tại đây (4.27 MB, 41 trang )
<span class='text_page_counter'>(1)</span><div class='page_container' data-page=1>
<b>Yes</b> <b>No</b>
<b>Fluid Infusion</b>
<b>1 liter NS</b> <b>SI >Normal</b> <b>SI Low</b> <b>SI High</b>
<b>Pressor</b> <b>Inotrope/</b>
<b>Vasodilator</b> <b>Diuretic</b>
<b>Volume Responsive: SVV>13%</b>
<b>1</b> <b>2</b> <b>3</b>
<b>William T. McGee, M.D., M.H.A. </b>
<b>FCCM, FCCP</b>
Intensivist
Baystate Medical Center, Springfield, MA
Associate Professor of Medicine and Surgery
Edwards Lifesciences
FloTrac/Vigileo/EV1000/ Clear
Sight
My cases; POPtm (free)
PICCO
LIDCO
Echo
Esophageal Doppler
Respirophasic change in SV
(SVV)
<b>Hospital mortality according to whether or not </b>
<b>patients achieved AIFR, CLFM, both, or neither.</b>
Murphy C V et al. Chest 2009;136:102-109
©2009 by American College of Chest
Physicians
intensivist
surgeon
cardiologist
Fool guessing!
1. Volume management is the most
important part of care of the critically ill
(<i><b>volume management is important )</b></i>
2. POP provides a simple physiology based
way to accomplish it
3. Physiology based care is important in the
ICU
Andrew K. Hilton & Rinaldo Bellomo
<i>Critical Care </i>2012, 16:302
<b>BAD Fluids! </b>
•The Question we ask on rounds every
day….
•Do we want to give more IVF?!?!?!?!?
•Is the patient fluid responsive?!?!?!?!?
Fundamentally, will fluid increase the
patient’s stroke volume and therefore
increase oxygen delivery?
Fluid ?
Pressor ?
Diuretic ?
1. Almost 0%
2. 25%
3. 50%
4. 75%
What is the impact on cardiac performance?
Requires a cardiac performance measure!
Ultimately
regarding Organ perfusion and function.
Answer: <b>Physiologic Optimization Program</b>
<b>Volume Status</b>
<b>Morbidity</b>
<b>/Mort</b>
<b>alit</b>
<b>y</b>
<b>Under</b> <b>Perfect</b> <b>Over</b>
<b>Relationship of Morbidity/Mortality </b>
<b>to Volume Status </b>
<b>for High-Risk Patients</b>
Relationship of Morbidity/Mortality to
Volume Status for High-Risk Patients
<b>30%</b>
<b>0%</b>
<b>Fluid Loading</b>
<b>B</b>
<b>Hypovolemia</b>
<b>Euvolemia</b>
<b>A</b> <b><sub>C</sub></b>
<b>Hypervolemia</b>
<b>D</b>
<b>SV</b>
<b>EDV</b>
<b>A</b>
<b>B</b>
<b>C</b>
<b>Per</b>
<b>io</b>
<b>p</b>
<b>er</b>
<b>ati</b>
<b>v</b>
<b>e </b>
<b>M</b>
<b>o</b>
<b>rb</b>
<b>id</b>
<b>it</b>
<b>y</b>
The Study and use of the cardiopulmonary
interaction to assess physiology Dynamic
measures of volume responsiveness Stroke
Volume Variation SVV and Pulse Pressure
Variation PPV
Ancient Chinese physicians
would assess a patient's pulse
for hours at a time to establish a
diagnosis. (<i>Pulsologists</i>) <b>2500 </b>
<b>BC</b>
<i><b>Muo Ching</b></i>
Described, differentiated and
diagnosed pulses in 10
volumes of books.
They could recognize more
than 200 different variations of
pulse based on volume,
strength, and regularity.
Positive Pressure Breath
↑ Intrathoracic pressure
<b>↑</b> RV afterload
<b>↓</b> RV Preload
Empty Pulmonary System
<b>Delayed ↓↓ SV</b>
<b>Acute</b> <b>↑ SV</b>
↑ LV Preload
McGee, WT;J Int. Care Med 2009; 24(6) p352
<b>The increase of preload volume is equal: ∆ EDV<sub>1</sub></b> <b>= ∆ EDV<sub>2</sub></b>
<b>starting point is not </b> <b>∆ SV<sub>1</sub></b> <b>>> ∆ SV<sub>2</sub></b>
<b>∆ SV (SVV) Starling Relationship: </b>
<b>Respiratory Variation in SV at Different </b>
<b>Preloads </b>
<b>EDV</b>
<b>SV</b>
<b>small variation</b>
<b>large variation</b>
<b>∆ EDV<sub>1</sub></b> <b>∆ EDV<sub>2</sub></b>
<b>∆ SV<sub>1</sub></b>
<b>∆ SV<sub>2</sub></b>
<b>∆ EDV (preload) caused by mechanical ventilation </b>
<b>SV – SVV Mirrors Frank-Starling EDV – SV Relationship</b>
<b>Preload Increases from A to B</b>
60
65
70
75
80
85
90
95
100
105
140 160 180 200 220 240 260
<b>EDV, (ml)</b>
<b>S</b>
<b>V</b>
<b>, </b>
<b>(m</b>
<b>l)</b>
60
65
70
75
80
85
90
0 5 10 15 20 25 30 35 40 45
<b>SVV, (%)</b>
<b>S</b>
<b>V</b>
<b>, </b>
<b>(m</b>
<b>l)</b>
<b>F-S relationship requires development; SV- SVV </b><i><b>allows </b></i>
<i><b>prediction</b></i> <b>about preload dependent cardiac performance </b>
<b>A</b> <b>A</b>
<b>B</b> <b>B</b>
<b>McGee,Hatib CCM 2007;34</b>
<b>SVV high</b>
SV
More variability
SVV high
Preload
<i><b>Sweet spot Goal </b></i>
Less variability
SVV low
SV/SVV pairs determine an individual’s position on
their Starling Curve
Sweet spot: max benefit from preload s volume
overload!
Provides a Goal for volume therapy.
A
<b>Distribution of Pulmonary-Artery–Occlusion Pressure (Panel A) and Central </b>
<b>Venous Pressure (Panel B) before Receipt of the First Protocol-Mandated </b>
<b>Instruction on Fluid Management.</b>
<b>The National Heart, Lung, and Blood Institute Acute Respiratory Distress </b>
<b>Syndrome (ARDS) Clinical Trials Network. N Engl J Med 2006;354:2213-2224.</b>
<b>Many had hydrostatic pulmonary edema (30%)</b>
<b>Likely preventable; CI≥nl 97%</b>
● Simulation/<i>standardization</i>
<b>Yes</b> <b>No</b>
<b>Fluid Infusion</b>
<b>1 liter NS</b> <b>SV Normal</b> <b>SV Low</b> <b>SV High</b>
<b>Pressor</b> <b>Inotrope/</b>
<b>Vasodilator</b> <b>Diuretic</b>
<b>Volume Responsive: SVV>10-15%</b>
<b>1</b> <b>2</b> <b>3</b>
Optimize perfusion and DO2
How:
SI Normal: <b>Pressor</b>
Vasodilation, severe sepsis or septic shock
SI Low: <b>Inotrope/Vasodilator</b>
Low output state Echo?
SI High: <b>Diuretic</b>
Acute lung injury, ARDS, or previous massive
resuscitation (wet lungs)
<b>The clinical impression of non-volume </b>
<b>responsive patients along with the </b>
<b>stroke index directs therapy. </b>
<b>1</b>
<b>2</b>
<b>3</b>
<b>P</b>
● Irregular Rhythm
● Spontaneous Breathing
● Insufficient Pleural Pressure Change
● Tachycardia >135
May be problematic:
Renal Failure
Passive leg-raising test consists of measuring
the hemodynamic effects: ΔSV/CO of a leg
elevation up to 45o
<b>45o</b>
<i><b>Semirecumbent position</b></i> <i><b>Passive leg raising</b></i>
<b>Responders get fluid</b>
<b>Non responders don’t! Improvement in SV requires </b>
<b>other therapy </b>
Teboul J-L and Monnet X. Prediction of volume responsiveness in critically ill patients
with spontaneous breathing activity. Curr Opin Crit Care. 2008:14(3);337
<i>No data exists that I am aware of that improving</i>
<i>DO2 is useful</i>
• SV cardiac performance measure: DO2
Individually assessed “adequate” baseline (OR)
or normal
• SVV volume responsiveness; α slope of F-S
Curve: if actively giving fluids goal
<b>Starling-ize our patients </b> <b>POP GDT</b>
<b>Optimization of volume therapy saves lives!</b>
<b>Manage volume therapy using physiology in </b>
<b>both directions</b>
<b>SV</b>
<b>More variability </b>
<b>SVV is high</b>
<b>Less variability </b>
<b>SVV is low </b>
<b>Preload</b>
Sweet spot
No DO2 change